Want to join the conversation?
$BCR, which competes with $COV, said it will benefit from incremental revenue in 2016 from the acquisitions of its Japanese JV and Liberator Medical. The company also expects to see a non-operating reduction to revenue from lower sales of EP products to $BSX and it is prepared for a range of levels for the Gore royalty.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?